nodes	percent_of_prediction	percent_of_DWPC	metapath
Captopril—MMP9—epilepsy syndrome	0.188	0.522	CbGaD
Captopril—CYP2D6—epilepsy syndrome	0.07	0.194	CbGaD
Captopril—ALB—epilepsy syndrome	0.0524	0.145	CbGaD
Captopril—ABCB1—epilepsy syndrome	0.05	0.139	CbGaD
Captopril—ALB—Oxcarbazepine—epilepsy syndrome	0.0354	0.112	CbGbCtD
Captopril—ALB—Fosphenytoin—epilepsy syndrome	0.0309	0.0981	CbGbCtD
Captopril—ALB—Clonazepam—epilepsy syndrome	0.028	0.0888	CbGbCtD
Captopril—ALB—Rufinamide—epilepsy syndrome	0.0228	0.0723	CbGbCtD
Captopril—SLC22A6—Acetazolamide—epilepsy syndrome	0.0209	0.0662	CbGbCtD
Captopril—ABCB1—Levetiracetam—epilepsy syndrome	0.0202	0.0642	CbGbCtD
Captopril—ALB—Phenytoin—epilepsy syndrome	0.0199	0.0632	CbGbCtD
Captopril—ALB—Propofol—epilepsy syndrome	0.0186	0.059	CbGbCtD
Captopril—ALB—Diazepam—epilepsy syndrome	0.0168	0.0534	CbGbCtD
Captopril—SLC22A6—Valproic Acid—epilepsy syndrome	0.0156	0.0495	CbGbCtD
Captopril—ABCB1—Clobazam—epilepsy syndrome	0.014	0.0445	CbGbCtD
Captopril—ABCB1—Lamotrigine—epilepsy syndrome	0.0135	0.0428	CbGbCtD
Captopril—ABCB1—Carbamazepine—epilepsy syndrome	0.0116	0.0369	CbGbCtD
Captopril—ABCB1—Phenytoin—epilepsy syndrome	0.0104	0.0331	CbGbCtD
Captopril—ABCB1—Phenobarbital—epilepsy syndrome	0.00929	0.0295	CbGbCtD
Captopril—ABCB1—Midazolam—epilepsy syndrome	0.00916	0.0291	CbGbCtD
Captopril—CYP2D6—Propofol—epilepsy syndrome	0.00916	0.0291	CbGbCtD
Captopril—ABCB1—Diazepam—epilepsy syndrome	0.00881	0.028	CbGbCtD
Captopril—REN—autonomic nervous system—epilepsy syndrome	0.00505	0.108	CbGeAlD
Captopril—F2—forelimb—epilepsy syndrome	0.00362	0.0776	CbGeAlD
Captopril—ACE—forelimb—epilepsy syndrome	0.00221	0.0474	CbGeAlD
Captopril—ACE—autonomic nervous system—epilepsy syndrome	0.00215	0.0461	CbGeAlD
Captopril—REN—hindbrain—epilepsy syndrome	0.00213	0.0456	CbGeAlD
Captopril—LTA4H—forebrain—epilepsy syndrome	0.00152	0.0327	CbGeAlD
Captopril—Enalapril—SLCO1A2—epilepsy syndrome	0.0014	0.85	CrCbGaD
Captopril—LTA4H—telencephalon—epilepsy syndrome	0.0014	0.03	CbGeAlD
Captopril—REN—brainstem—epilepsy syndrome	0.00122	0.0261	CbGeAlD
Captopril—ACE—ganglion—epilepsy syndrome	0.00119	0.0256	CbGeAlD
Captopril—REN—forebrain—epilepsy syndrome	0.00118	0.0252	CbGeAlD
Captopril—LTA4H—medulla oblongata—epilepsy syndrome	0.0011	0.0236	CbGeAlD
Captopril—LTA4H—midbrain—epilepsy syndrome	0.00101	0.0216	CbGeAlD
Captopril—LTA4H—spinal cord—epilepsy syndrome	0.000982	0.021	CbGeAlD
Captopril—LTA4H—head—epilepsy syndrome	0.000873	0.0187	CbGeAlD
Captopril—LTA4H—nervous system—epilepsy syndrome	0.000827	0.0177	CbGeAlD
Captopril—LTA4H—central nervous system—epilepsy syndrome	0.000796	0.0171	CbGeAlD
Captopril—MMP2—medulla oblongata—epilepsy syndrome	0.000781	0.0167	CbGeAlD
Captopril—LTA4H—cerebellum—epilepsy syndrome	0.000778	0.0167	CbGeAlD
Captopril—MMP2—midbrain—epilepsy syndrome	0.000714	0.0153	CbGeAlD
Captopril—MMP2—spinal cord—epilepsy syndrome	0.000697	0.0149	CbGeAlD
Captopril—REN—head—epilepsy syndrome	0.000673	0.0144	CbGeAlD
Captopril—REN—nervous system—epilepsy syndrome	0.000639	0.0137	CbGeAlD
Captopril—LTA4H—brain—epilepsy syndrome	0.000632	0.0135	CbGeAlD
Captopril—MMP2—head—epilepsy syndrome	0.000619	0.0133	CbGeAlD
Captopril—REN—central nervous system—epilepsy syndrome	0.000615	0.0132	CbGeAlD
Captopril—MMP9—spinal cord—epilepsy syndrome	0.000606	0.013	CbGeAlD
Captopril—REN—cerebellum—epilepsy syndrome	0.000601	0.0129	CbGeAlD
Captopril—MMP2—nervous system—epilepsy syndrome	0.000587	0.0126	CbGeAlD
Captopril—MMP2—central nervous system—epilepsy syndrome	0.000565	0.0121	CbGeAlD
Captopril—MMP9—head—epilepsy syndrome	0.000538	0.0115	CbGeAlD
Captopril—F2—spinal cord—epilepsy syndrome	0.000529	0.0113	CbGeAlD
Captopril—MMP9—nervous system—epilepsy syndrome	0.00051	0.0109	CbGeAlD
Captopril—ACE—forebrain—epilepsy syndrome	0.000501	0.0107	CbGeAlD
Captopril—MMP9—central nervous system—epilepsy syndrome	0.000491	0.0105	CbGeAlD
Captopril—REN—brain—epilepsy syndrome	0.000488	0.0105	CbGeAlD
Captopril—F2—head—epilepsy syndrome	0.00047	0.0101	CbGeAlD
Captopril—ACE—telencephalon—epilepsy syndrome	0.000461	0.00988	CbGeAlD
Captopril—MMP2—brain—epilepsy syndrome	0.000449	0.00961	CbGeAlD
Captopril—F2—nervous system—epilepsy syndrome	0.000445	0.00954	CbGeAlD
Captopril—CYP2D6—hindbrain—epilepsy syndrome	0.000443	0.0095	CbGeAlD
Captopril—F2—central nervous system—epilepsy syndrome	0.000429	0.00919	CbGeAlD
Captopril—MMP9—brain—epilepsy syndrome	0.00039	0.00836	CbGeAlD
Captopril—SLC22A6—brain—epilepsy syndrome	0.000349	0.00747	CbGeAlD
Captopril—F2—brain—epilepsy syndrome	0.00034	0.00729	CbGeAlD
Captopril—ACE—spinal cord—epilepsy syndrome	0.000323	0.00692	CbGeAlD
Captopril—ACE—head—epilepsy syndrome	0.000287	0.00615	CbGeAlD
Captopril—ACE—nervous system—epilepsy syndrome	0.000272	0.00583	CbGeAlD
Captopril—ACE—central nervous system—epilepsy syndrome	0.000262	0.00561	CbGeAlD
Captopril—CYP2D6—brainstem—epilepsy syndrome	0.000254	0.00545	CbGeAlD
Captopril—Enalapril—ABCB1—epilepsy syndrome	0.000247	0.15	CrCbGaD
Captopril—CYP2D6—forebrain—epilepsy syndrome	0.000245	0.00526	CbGeAlD
Captopril—CYP2D6—telencephalon—epilepsy syndrome	0.000226	0.00483	CbGeAlD
Captopril—ALB—brain—epilepsy syndrome	0.000217	0.00466	CbGeAlD
Captopril—ACE—brain—epilepsy syndrome	0.000208	0.00446	CbGeAlD
Captopril—ABCB1—forebrain—epilepsy syndrome	0.000176	0.00378	CbGeAlD
Captopril—ABCB1—telencephalon—epilepsy syndrome	0.000162	0.00348	CbGeAlD
Captopril—CYP2D6—head—epilepsy syndrome	0.00014	0.00301	CbGeAlD
Captopril—CYP2D6—nervous system—epilepsy syndrome	0.000133	0.00285	CbGeAlD
Captopril—CYP2D6—central nervous system—epilepsy syndrome	0.000128	0.00275	CbGeAlD
Captopril—ABCB1—medulla oblongata—epilepsy syndrome	0.000127	0.00273	CbGeAlD
Captopril—CYP2D6—cerebellum—epilepsy syndrome	0.000125	0.00268	CbGeAlD
Captopril—ABCB1—midbrain—epilepsy syndrome	0.000117	0.0025	CbGeAlD
Captopril—ABCB1—spinal cord—epilepsy syndrome	0.000114	0.00244	CbGeAlD
Captopril—CYP2D6—brain—epilepsy syndrome	0.000102	0.00218	CbGeAlD
Captopril—ABCB1—head—epilepsy syndrome	0.000101	0.00216	CbGeAlD
Captopril—ABCB1—nervous system—epilepsy syndrome	9.58e-05	0.00205	CbGeAlD
Captopril—ABCB1—central nervous system—epilepsy syndrome	9.22e-05	0.00198	CbGeAlD
Captopril—ABCB1—cerebellum—epilepsy syndrome	9.01e-05	0.00193	CbGeAlD
Captopril—ABCB1—brain—epilepsy syndrome	7.32e-05	0.00157	CbGeAlD
Captopril—Asthenia—Zonisamide—epilepsy syndrome	5.63e-05	0.000337	CcSEcCtD
Captopril—Agranulocytosis—Topiramate—epilepsy syndrome	5.62e-05	0.000336	CcSEcCtD
Captopril—Dry mouth—Valproic Acid—epilepsy syndrome	5.62e-05	0.000336	CcSEcCtD
Captopril—Headache—Levetiracetam—epilepsy syndrome	5.6e-05	0.000335	CcSEcCtD
Captopril—Angioedema—Pregabalin—epilepsy syndrome	5.57e-05	0.000333	CcSEcCtD
Captopril—Dizziness—Vigabatrin—epilepsy syndrome	5.56e-05	0.000333	CcSEcCtD
Captopril—Confusional state—Valproic Acid—epilepsy syndrome	5.55e-05	0.000332	CcSEcCtD
Captopril—Pruritus—Zonisamide—epilepsy syndrome	5.55e-05	0.000332	CcSEcCtD
Captopril—Anaphylactic shock—Valproic Acid—epilepsy syndrome	5.51e-05	0.000329	CcSEcCtD
Captopril—Malaise—Pregabalin—epilepsy syndrome	5.5e-05	0.000329	CcSEcCtD
Captopril—Nausea—Propofol—epilepsy syndrome	5.5e-05	0.000329	CcSEcCtD
Captopril—Tension—Gabapentin—epilepsy syndrome	5.49e-05	0.000328	CcSEcCtD
Captopril—Vomiting—Fosphenytoin—epilepsy syndrome	5.49e-05	0.000328	CcSEcCtD
Captopril—Diarrhoea—Felbamate—epilepsy syndrome	5.49e-05	0.000328	CcSEcCtD
Captopril—Abdominal pain—Lamotrigine—epilepsy syndrome	5.48e-05	0.000328	CcSEcCtD
Captopril—Body temperature increased—Lamotrigine—epilepsy syndrome	5.48e-05	0.000328	CcSEcCtD
Captopril—Dysgeusia—Gabapentin—epilepsy syndrome	5.48e-05	0.000328	CcSEcCtD
Captopril—Dizziness—Diazepam—epilepsy syndrome	5.48e-05	0.000328	CcSEcCtD
Captopril—Syncope—Pregabalin—epilepsy syndrome	5.47e-05	0.000327	CcSEcCtD
Captopril—Rash—Fosphenytoin—epilepsy syndrome	5.44e-05	0.000326	CcSEcCtD
Captopril—Dermatitis—Fosphenytoin—epilepsy syndrome	5.44e-05	0.000325	CcSEcCtD
Captopril—Nervousness—Gabapentin—epilepsy syndrome	5.43e-05	0.000325	CcSEcCtD
Captopril—Asthenia—Clonazepam—epilepsy syndrome	5.43e-05	0.000325	CcSEcCtD
Captopril—Rhinitis—Topiramate—epilepsy syndrome	5.42e-05	0.000324	CcSEcCtD
Captopril—Headache—Fosphenytoin—epilepsy syndrome	5.41e-05	0.000323	CcSEcCtD
Captopril—Hepatitis—Topiramate—epilepsy syndrome	5.41e-05	0.000323	CcSEcCtD
Captopril—Thrombocytopenia—Valproic Acid—epilepsy syndrome	5.39e-05	0.000323	CcSEcCtD
Captopril—Palpitations—Pregabalin—epilepsy syndrome	5.39e-05	0.000322	CcSEcCtD
Captopril—Asthenia—Phenytoin—epilepsy syndrome	5.39e-05	0.000322	CcSEcCtD
Captopril—Nausea—Midazolam—epilepsy syndrome	5.38e-05	0.000322	CcSEcCtD
Captopril—Hallucination—Topiramate—epilepsy syndrome	5.38e-05	0.000322	CcSEcCtD
Captopril—Tachycardia—Valproic Acid—epilepsy syndrome	5.37e-05	0.000322	CcSEcCtD
Captopril—Diarrhoea—Zonisamide—epilepsy syndrome	5.37e-05	0.000321	CcSEcCtD
Captopril—Pharyngitis—Topiramate—epilepsy syndrome	5.37e-05	0.000321	CcSEcCtD
Captopril—Loss of consciousness—Pregabalin—epilepsy syndrome	5.36e-05	0.000321	CcSEcCtD
Captopril—Asthenia—Oxcarbazepine—epilepsy syndrome	5.36e-05	0.000321	CcSEcCtD
Captopril—Pruritus—Clonazepam—epilepsy syndrome	5.35e-05	0.00032	CcSEcCtD
Captopril—Vomiting—Vigabatrin—epilepsy syndrome	5.35e-05	0.00032	CcSEcCtD
Captopril—Cough—Pregabalin—epilepsy syndrome	5.32e-05	0.000318	CcSEcCtD
Captopril—Pruritus—Phenytoin—epilepsy syndrome	5.31e-05	0.000318	CcSEcCtD
Captopril—Nausea—Levetiracetam—epilepsy syndrome	5.31e-05	0.000318	CcSEcCtD
Captopril—Rash—Vigabatrin—epilepsy syndrome	5.3e-05	0.000317	CcSEcCtD
Captopril—Dizziness—Felbamate—epilepsy syndrome	5.3e-05	0.000317	CcSEcCtD
Captopril—Dermatitis—Vigabatrin—epilepsy syndrome	5.3e-05	0.000317	CcSEcCtD
Captopril—Pruritus—Oxcarbazepine—epilepsy syndrome	5.29e-05	0.000316	CcSEcCtD
Captopril—Vision blurred—Gabapentin—epilepsy syndrome	5.27e-05	0.000315	CcSEcCtD
Captopril—Headache—Vigabatrin—epilepsy syndrome	5.27e-05	0.000315	CcSEcCtD
Captopril—Vomiting—Diazepam—epilepsy syndrome	5.27e-05	0.000315	CcSEcCtD
Captopril—Anorexia—Valproic Acid—epilepsy syndrome	5.25e-05	0.000314	CcSEcCtD
Captopril—Rash—Diazepam—epilepsy syndrome	5.22e-05	0.000312	CcSEcCtD
Captopril—Dermatitis—Diazepam—epilepsy syndrome	5.22e-05	0.000312	CcSEcCtD
Captopril—Arthralgia—Pregabalin—epilepsy syndrome	5.19e-05	0.000311	CcSEcCtD
Captopril—Myalgia—Pregabalin—epilepsy syndrome	5.19e-05	0.000311	CcSEcCtD
Captopril—Chest pain—Pregabalin—epilepsy syndrome	5.19e-05	0.000311	CcSEcCtD
Captopril—Ill-defined disorder—Gabapentin—epilepsy syndrome	5.19e-05	0.00031	CcSEcCtD
Captopril—Dizziness—Zonisamide—epilepsy syndrome	5.19e-05	0.00031	CcSEcCtD
Captopril—Headache—Diazepam—epilepsy syndrome	5.19e-05	0.00031	CcSEcCtD
Captopril—Diarrhoea—Clonazepam—epilepsy syndrome	5.17e-05	0.00031	CcSEcCtD
Captopril—Anaemia—Gabapentin—epilepsy syndrome	5.17e-05	0.000309	CcSEcCtD
Captopril—Hypotension—Valproic Acid—epilepsy syndrome	5.15e-05	0.000308	CcSEcCtD
Captopril—Asthenia—Carbamazepine—epilepsy syndrome	5.14e-05	0.000308	CcSEcCtD
Captopril—Diarrhoea—Phenytoin—epilepsy syndrome	5.14e-05	0.000307	CcSEcCtD
Captopril—Discomfort—Pregabalin—epilepsy syndrome	5.13e-05	0.000307	CcSEcCtD
Captopril—Nausea—Fosphenytoin—epilepsy syndrome	5.13e-05	0.000307	CcSEcCtD
Captopril—Diarrhoea—Oxcarbazepine—epilepsy syndrome	5.11e-05	0.000306	CcSEcCtD
Captopril—Erythema multiforme—Topiramate—epilepsy syndrome	5.11e-05	0.000306	CcSEcCtD
Captopril—Angioedema—Gabapentin—epilepsy syndrome	5.11e-05	0.000306	CcSEcCtD
Captopril—Vomiting—Felbamate—epilepsy syndrome	5.1e-05	0.000305	CcSEcCtD
Captopril—Dry mouth—Pregabalin—epilepsy syndrome	5.08e-05	0.000304	CcSEcCtD
Captopril—Pruritus—Carbamazepine—epilepsy syndrome	5.07e-05	0.000303	CcSEcCtD
Captopril—Rash—Felbamate—epilepsy syndrome	5.05e-05	0.000302	CcSEcCtD
Captopril—Dermatitis—Felbamate—epilepsy syndrome	5.05e-05	0.000302	CcSEcCtD
Captopril—Malaise—Gabapentin—epilepsy syndrome	5.04e-05	0.000302	CcSEcCtD
Captopril—Headache—Felbamate—epilepsy syndrome	5.02e-05	0.0003	CcSEcCtD
Captopril—Confusional state—Pregabalin—epilepsy syndrome	5.02e-05	0.0003	CcSEcCtD
Captopril—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	5.02e-05	0.0003	CcSEcCtD
Captopril—Flushing—Topiramate—epilepsy syndrome	5.02e-05	0.0003	CcSEcCtD
Captopril—Syncope—Gabapentin—epilepsy syndrome	5.02e-05	0.0003	CcSEcCtD
Captopril—Dizziness—Clonazepam—epilepsy syndrome	5e-05	0.000299	CcSEcCtD
Captopril—Nausea—Vigabatrin—epilepsy syndrome	5e-05	0.000299	CcSEcCtD
Captopril—Vomiting—Zonisamide—epilepsy syndrome	4.99e-05	0.000298	CcSEcCtD
Captopril—Insomnia—Valproic Acid—epilepsy syndrome	4.98e-05	0.000298	CcSEcCtD
Captopril—Anaphylactic shock—Pregabalin—epilepsy syndrome	4.98e-05	0.000298	CcSEcCtD
Captopril—Asthenia—Lamotrigine—epilepsy syndrome	4.97e-05	0.000297	CcSEcCtD
Captopril—Dizziness—Phenytoin—epilepsy syndrome	4.97e-05	0.000297	CcSEcCtD
Captopril—Rash—Zonisamide—epilepsy syndrome	4.95e-05	0.000296	CcSEcCtD
Captopril—Paraesthesia—Valproic Acid—epilepsy syndrome	4.94e-05	0.000296	CcSEcCtD
Captopril—Palpitations—Gabapentin—epilepsy syndrome	4.94e-05	0.000296	CcSEcCtD
Captopril—Dermatitis—Zonisamide—epilepsy syndrome	4.94e-05	0.000296	CcSEcCtD
Captopril—Dizziness—Oxcarbazepine—epilepsy syndrome	4.94e-05	0.000296	CcSEcCtD
Captopril—Nausea—Diazepam—epilepsy syndrome	4.92e-05	0.000294	CcSEcCtD
Captopril—Loss of consciousness—Gabapentin—epilepsy syndrome	4.92e-05	0.000294	CcSEcCtD
Captopril—Headache—Zonisamide—epilepsy syndrome	4.92e-05	0.000294	CcSEcCtD
Captopril—Dyspnoea—Valproic Acid—epilepsy syndrome	4.91e-05	0.000294	CcSEcCtD
Captopril—Diarrhoea—Carbamazepine—epilepsy syndrome	4.91e-05	0.000293	CcSEcCtD
Captopril—Pruritus—Lamotrigine—epilepsy syndrome	4.9e-05	0.000293	CcSEcCtD
Captopril—Shock—Pregabalin—epilepsy syndrome	4.9e-05	0.000293	CcSEcCtD
Captopril—Somnolence—Valproic Acid—epilepsy syndrome	4.9e-05	0.000293	CcSEcCtD
Captopril—Cough—Gabapentin—epilepsy syndrome	4.88e-05	0.000292	CcSEcCtD
Captopril—Thrombocytopenia—Pregabalin—epilepsy syndrome	4.87e-05	0.000292	CcSEcCtD
Captopril—Tachycardia—Pregabalin—epilepsy syndrome	4.86e-05	0.000291	CcSEcCtD
Captopril—Dyspepsia—Valproic Acid—epilepsy syndrome	4.85e-05	0.00029	CcSEcCtD
Captopril—Vomiting—Clonazepam—epilepsy syndrome	4.81e-05	0.000288	CcSEcCtD
Captopril—Decreased appetite—Valproic Acid—epilepsy syndrome	4.79e-05	0.000286	CcSEcCtD
Captopril—Alopecia—Topiramate—epilepsy syndrome	4.78e-05	0.000286	CcSEcCtD
Captopril—Vomiting—Phenytoin—epilepsy syndrome	4.78e-05	0.000286	CcSEcCtD
Captopril—Rash—Clonazepam—epilepsy syndrome	4.77e-05	0.000285	CcSEcCtD
Captopril—Dermatitis—Clonazepam—epilepsy syndrome	4.76e-05	0.000285	CcSEcCtD
Captopril—Arthralgia—Gabapentin—epilepsy syndrome	4.76e-05	0.000285	CcSEcCtD
Captopril—Chest pain—Gabapentin—epilepsy syndrome	4.76e-05	0.000285	CcSEcCtD
Captopril—Myalgia—Gabapentin—epilepsy syndrome	4.76e-05	0.000285	CcSEcCtD
Captopril—Nausea—Felbamate—epilepsy syndrome	4.76e-05	0.000285	CcSEcCtD
Captopril—Vomiting—Oxcarbazepine—epilepsy syndrome	4.75e-05	0.000284	CcSEcCtD
Captopril—Fatigue—Valproic Acid—epilepsy syndrome	4.75e-05	0.000284	CcSEcCtD
Captopril—Anorexia—Pregabalin—epilepsy syndrome	4.75e-05	0.000284	CcSEcCtD
Captopril—Dizziness—Carbamazepine—epilepsy syndrome	4.74e-05	0.000284	CcSEcCtD
Captopril—Diarrhoea—Lamotrigine—epilepsy syndrome	4.74e-05	0.000284	CcSEcCtD
Captopril—Headache—Clonazepam—epilepsy syndrome	4.74e-05	0.000283	CcSEcCtD
Captopril—Rash—Phenytoin—epilepsy syndrome	4.74e-05	0.000283	CcSEcCtD
Captopril—Dermatitis—Phenytoin—epilepsy syndrome	4.73e-05	0.000283	CcSEcCtD
Captopril—Rash—Oxcarbazepine—epilepsy syndrome	4.71e-05	0.000282	CcSEcCtD
Captopril—Constipation—Valproic Acid—epilepsy syndrome	4.71e-05	0.000282	CcSEcCtD
Captopril—Dermatitis—Oxcarbazepine—epilepsy syndrome	4.71e-05	0.000282	CcSEcCtD
Captopril—Headache—Phenytoin—epilepsy syndrome	4.71e-05	0.000282	CcSEcCtD
Captopril—Discomfort—Gabapentin—epilepsy syndrome	4.71e-05	0.000281	CcSEcCtD
Captopril—Headache—Oxcarbazepine—epilepsy syndrome	4.68e-05	0.00028	CcSEcCtD
Captopril—Nausea—Zonisamide—epilepsy syndrome	4.66e-05	0.000279	CcSEcCtD
Captopril—Dry mouth—Gabapentin—epilepsy syndrome	4.66e-05	0.000279	CcSEcCtD
Captopril—Hypotension—Pregabalin—epilepsy syndrome	4.65e-05	0.000278	CcSEcCtD
Captopril—Tension—Topiramate—epilepsy syndrome	4.62e-05	0.000276	CcSEcCtD
Captopril—Dysgeusia—Topiramate—epilepsy syndrome	4.61e-05	0.000276	CcSEcCtD
Captopril—Confusional state—Gabapentin—epilepsy syndrome	4.6e-05	0.000275	CcSEcCtD
Captopril—Dizziness—Lamotrigine—epilepsy syndrome	4.58e-05	0.000274	CcSEcCtD
Captopril—Nervousness—Topiramate—epilepsy syndrome	4.57e-05	0.000273	CcSEcCtD
Captopril—Anaphylactic shock—Gabapentin—epilepsy syndrome	4.57e-05	0.000273	CcSEcCtD
Captopril—Vomiting—Carbamazepine—epilepsy syndrome	4.56e-05	0.000273	CcSEcCtD
Captopril—Feeling abnormal—Valproic Acid—epilepsy syndrome	4.54e-05	0.000271	CcSEcCtD
Captopril—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	4.54e-05	0.000271	CcSEcCtD
Captopril—Rash—Carbamazepine—epilepsy syndrome	4.52e-05	0.00027	CcSEcCtD
Captopril—Dermatitis—Carbamazepine—epilepsy syndrome	4.52e-05	0.00027	CcSEcCtD
Captopril—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	4.5e-05	0.000269	CcSEcCtD
Captopril—Insomnia—Pregabalin—epilepsy syndrome	4.5e-05	0.000269	CcSEcCtD
Captopril—Nausea—Clonazepam—epilepsy syndrome	4.49e-05	0.000269	CcSEcCtD
Captopril—Headache—Carbamazepine—epilepsy syndrome	4.49e-05	0.000269	CcSEcCtD
Captopril—Shock—Gabapentin—epilepsy syndrome	4.49e-05	0.000269	CcSEcCtD
Captopril—Paraesthesia—Pregabalin—epilepsy syndrome	4.47e-05	0.000267	CcSEcCtD
Captopril—Thrombocytopenia—Gabapentin—epilepsy syndrome	4.47e-05	0.000267	CcSEcCtD
Captopril—Nausea—Phenytoin—epilepsy syndrome	4.46e-05	0.000267	CcSEcCtD
Captopril—Tachycardia—Gabapentin—epilepsy syndrome	4.46e-05	0.000267	CcSEcCtD
Captopril—Dyspnoea—Pregabalin—epilepsy syndrome	4.44e-05	0.000266	CcSEcCtD
Captopril—Nausea—Oxcarbazepine—epilepsy syndrome	4.44e-05	0.000266	CcSEcCtD
Captopril—Vision blurred—Topiramate—epilepsy syndrome	4.44e-05	0.000265	CcSEcCtD
Captopril—Somnolence—Pregabalin—epilepsy syndrome	4.43e-05	0.000265	CcSEcCtD
Captopril—Vomiting—Lamotrigine—epilepsy syndrome	4.41e-05	0.000264	CcSEcCtD
Captopril—Rash—Lamotrigine—epilepsy syndrome	4.37e-05	0.000261	CcSEcCtD
Captopril—Ill-defined disorder—Topiramate—epilepsy syndrome	4.37e-05	0.000261	CcSEcCtD
Captopril—Dermatitis—Lamotrigine—epilepsy syndrome	4.37e-05	0.000261	CcSEcCtD
Captopril—Body temperature increased—Valproic Acid—epilepsy syndrome	4.35e-05	0.00026	CcSEcCtD
Captopril—Abdominal pain—Valproic Acid—epilepsy syndrome	4.35e-05	0.00026	CcSEcCtD
Captopril—Anorexia—Gabapentin—epilepsy syndrome	4.35e-05	0.00026	CcSEcCtD
Captopril—Anaemia—Topiramate—epilepsy syndrome	4.35e-05	0.00026	CcSEcCtD
Captopril—Headache—Lamotrigine—epilepsy syndrome	4.34e-05	0.00026	CcSEcCtD
Captopril—Decreased appetite—Pregabalin—epilepsy syndrome	4.33e-05	0.000259	CcSEcCtD
Captopril—Fatigue—Pregabalin—epilepsy syndrome	4.29e-05	0.000257	CcSEcCtD
Captopril—Hypotension—Gabapentin—epilepsy syndrome	4.27e-05	0.000255	CcSEcCtD
Captopril—Nausea—Carbamazepine—epilepsy syndrome	4.26e-05	0.000255	CcSEcCtD
Captopril—Constipation—Pregabalin—epilepsy syndrome	4.26e-05	0.000255	CcSEcCtD
Captopril—Malaise—Topiramate—epilepsy syndrome	4.24e-05	0.000254	CcSEcCtD
Captopril—Syncope—Topiramate—epilepsy syndrome	4.22e-05	0.000252	CcSEcCtD
Captopril—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	4.16e-05	0.000249	CcSEcCtD
Captopril—Palpitations—Topiramate—epilepsy syndrome	4.16e-05	0.000249	CcSEcCtD
Captopril—Loss of consciousness—Topiramate—epilepsy syndrome	4.14e-05	0.000247	CcSEcCtD
Captopril—Insomnia—Gabapentin—epilepsy syndrome	4.13e-05	0.000247	CcSEcCtD
Captopril—Nausea—Lamotrigine—epilepsy syndrome	4.12e-05	0.000246	CcSEcCtD
Captopril—Cough—Topiramate—epilepsy syndrome	4.11e-05	0.000246	CcSEcCtD
Captopril—Feeling abnormal—Pregabalin—epilepsy syndrome	4.1e-05	0.000245	CcSEcCtD
Captopril—Paraesthesia—Gabapentin—epilepsy syndrome	4.1e-05	0.000245	CcSEcCtD
Captopril—Gastrointestinal pain—Pregabalin—epilepsy syndrome	4.07e-05	0.000244	CcSEcCtD
Captopril—Dyspnoea—Gabapentin—epilepsy syndrome	4.07e-05	0.000243	CcSEcCtD
Captopril—Somnolence—Gabapentin—epilepsy syndrome	4.06e-05	0.000243	CcSEcCtD
Captopril—Dyspepsia—Gabapentin—epilepsy syndrome	4.02e-05	0.00024	CcSEcCtD
Captopril—Myalgia—Topiramate—epilepsy syndrome	4.01e-05	0.00024	CcSEcCtD
Captopril—Chest pain—Topiramate—epilepsy syndrome	4.01e-05	0.00024	CcSEcCtD
Captopril—Arthralgia—Topiramate—epilepsy syndrome	4.01e-05	0.00024	CcSEcCtD
Captopril—Decreased appetite—Gabapentin—epilepsy syndrome	3.97e-05	0.000237	CcSEcCtD
Captopril—Discomfort—Topiramate—epilepsy syndrome	3.96e-05	0.000237	CcSEcCtD
Captopril—Asthenia—Valproic Acid—epilepsy syndrome	3.95e-05	0.000236	CcSEcCtD
Captopril—Fatigue—Gabapentin—epilepsy syndrome	3.94e-05	0.000235	CcSEcCtD
Captopril—Abdominal pain—Pregabalin—epilepsy syndrome	3.94e-05	0.000235	CcSEcCtD
Captopril—Body temperature increased—Pregabalin—epilepsy syndrome	3.94e-05	0.000235	CcSEcCtD
Captopril—Dry mouth—Topiramate—epilepsy syndrome	3.92e-05	0.000234	CcSEcCtD
Captopril—Constipation—Gabapentin—epilepsy syndrome	3.9e-05	0.000234	CcSEcCtD
Captopril—Pruritus—Valproic Acid—epilepsy syndrome	3.9e-05	0.000233	CcSEcCtD
Captopril—Confusional state—Topiramate—epilepsy syndrome	3.87e-05	0.000232	CcSEcCtD
Captopril—Shock—Topiramate—epilepsy syndrome	3.78e-05	0.000226	CcSEcCtD
Captopril—Diarrhoea—Valproic Acid—epilepsy syndrome	3.77e-05	0.000225	CcSEcCtD
Captopril—Feeling abnormal—Gabapentin—epilepsy syndrome	3.76e-05	0.000225	CcSEcCtD
Captopril—Thrombocytopenia—Topiramate—epilepsy syndrome	3.76e-05	0.000225	CcSEcCtD
Captopril—Tachycardia—Topiramate—epilepsy syndrome	3.75e-05	0.000224	CcSEcCtD
Captopril—Gastrointestinal pain—Gabapentin—epilepsy syndrome	3.73e-05	0.000223	CcSEcCtD
Captopril—Anorexia—Topiramate—epilepsy syndrome	3.66e-05	0.000219	CcSEcCtD
Captopril—Dizziness—Valproic Acid—epilepsy syndrome	3.64e-05	0.000218	CcSEcCtD
Captopril—Body temperature increased—Gabapentin—epilepsy syndrome	3.61e-05	0.000216	CcSEcCtD
Captopril—Abdominal pain—Gabapentin—epilepsy syndrome	3.61e-05	0.000216	CcSEcCtD
Captopril—Hypotension—Topiramate—epilepsy syndrome	3.59e-05	0.000215	CcSEcCtD
Captopril—Asthenia—Pregabalin—epilepsy syndrome	3.57e-05	0.000214	CcSEcCtD
Captopril—Pruritus—Pregabalin—epilepsy syndrome	3.52e-05	0.000211	CcSEcCtD
Captopril—Vomiting—Valproic Acid—epilepsy syndrome	3.5e-05	0.000209	CcSEcCtD
Captopril—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	3.5e-05	0.000209	CcSEcCtD
Captopril—Insomnia—Topiramate—epilepsy syndrome	3.47e-05	0.000208	CcSEcCtD
Captopril—Rash—Valproic Acid—epilepsy syndrome	3.47e-05	0.000208	CcSEcCtD
Captopril—Dermatitis—Valproic Acid—epilepsy syndrome	3.47e-05	0.000208	CcSEcCtD
Captopril—Headache—Valproic Acid—epilepsy syndrome	3.45e-05	0.000206	CcSEcCtD
Captopril—Paraesthesia—Topiramate—epilepsy syndrome	3.45e-05	0.000206	CcSEcCtD
Captopril—Dyspnoea—Topiramate—epilepsy syndrome	3.42e-05	0.000205	CcSEcCtD
Captopril—Somnolence—Topiramate—epilepsy syndrome	3.41e-05	0.000204	CcSEcCtD
Captopril—Diarrhoea—Pregabalin—epilepsy syndrome	3.41e-05	0.000204	CcSEcCtD
Captopril—Dyspepsia—Topiramate—epilepsy syndrome	3.38e-05	0.000202	CcSEcCtD
Captopril—Decreased appetite—Topiramate—epilepsy syndrome	3.34e-05	0.0002	CcSEcCtD
Captopril—Fatigue—Topiramate—epilepsy syndrome	3.31e-05	0.000198	CcSEcCtD
Captopril—Dizziness—Pregabalin—epilepsy syndrome	3.29e-05	0.000197	CcSEcCtD
Captopril—Constipation—Topiramate—epilepsy syndrome	3.28e-05	0.000196	CcSEcCtD
Captopril—Asthenia—Gabapentin—epilepsy syndrome	3.28e-05	0.000196	CcSEcCtD
Captopril—Nausea—Valproic Acid—epilepsy syndrome	3.27e-05	0.000196	CcSEcCtD
Captopril—Pruritus—Gabapentin—epilepsy syndrome	3.23e-05	0.000193	CcSEcCtD
Captopril—Vomiting—Pregabalin—epilepsy syndrome	3.17e-05	0.000189	CcSEcCtD
Captopril—Feeling abnormal—Topiramate—epilepsy syndrome	3.17e-05	0.000189	CcSEcCtD
Captopril—Gastrointestinal pain—Topiramate—epilepsy syndrome	3.14e-05	0.000188	CcSEcCtD
Captopril—Rash—Pregabalin—epilepsy syndrome	3.14e-05	0.000188	CcSEcCtD
Captopril—Dermatitis—Pregabalin—epilepsy syndrome	3.14e-05	0.000188	CcSEcCtD
Captopril—Diarrhoea—Gabapentin—epilepsy syndrome	3.12e-05	0.000187	CcSEcCtD
Captopril—Headache—Pregabalin—epilepsy syndrome	3.12e-05	0.000187	CcSEcCtD
Captopril—Body temperature increased—Topiramate—epilepsy syndrome	3.04e-05	0.000182	CcSEcCtD
Captopril—Abdominal pain—Topiramate—epilepsy syndrome	3.04e-05	0.000182	CcSEcCtD
Captopril—Dizziness—Gabapentin—epilepsy syndrome	3.02e-05	0.000181	CcSEcCtD
Captopril—Nausea—Pregabalin—epilepsy syndrome	2.96e-05	0.000177	CcSEcCtD
Captopril—Vomiting—Gabapentin—epilepsy syndrome	2.9e-05	0.000174	CcSEcCtD
Captopril—Rash—Gabapentin—epilepsy syndrome	2.88e-05	0.000172	CcSEcCtD
Captopril—Dermatitis—Gabapentin—epilepsy syndrome	2.88e-05	0.000172	CcSEcCtD
Captopril—Headache—Gabapentin—epilepsy syndrome	2.86e-05	0.000171	CcSEcCtD
Captopril—Asthenia—Topiramate—epilepsy syndrome	2.76e-05	0.000165	CcSEcCtD
Captopril—Pruritus—Topiramate—epilepsy syndrome	2.72e-05	0.000163	CcSEcCtD
Captopril—Nausea—Gabapentin—epilepsy syndrome	2.71e-05	0.000162	CcSEcCtD
Captopril—Diarrhoea—Topiramate—epilepsy syndrome	2.63e-05	0.000157	CcSEcCtD
Captopril—Dizziness—Topiramate—epilepsy syndrome	2.54e-05	0.000152	CcSEcCtD
Captopril—Vomiting—Topiramate—epilepsy syndrome	2.44e-05	0.000146	CcSEcCtD
Captopril—Rash—Topiramate—epilepsy syndrome	2.42e-05	0.000145	CcSEcCtD
Captopril—Dermatitis—Topiramate—epilepsy syndrome	2.42e-05	0.000145	CcSEcCtD
Captopril—Headache—Topiramate—epilepsy syndrome	2.41e-05	0.000144	CcSEcCtD
Captopril—Nausea—Topiramate—epilepsy syndrome	2.28e-05	0.000136	CcSEcCtD
Captopril—CYP2D6—Metabolism—COX3—epilepsy syndrome	6.87e-06	6.33e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—ADAM10—epilepsy syndrome	6.86e-06	6.31e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—NOS1—epilepsy syndrome	6.77e-06	6.24e-05	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—HTR2A—epilepsy syndrome	6.74e-06	6.21e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—GBE1—epilepsy syndrome	6.71e-06	6.18e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—PPP1R3C—epilepsy syndrome	6.71e-06	6.18e-05	CbGpPWpGaD
Captopril—ABCB1—HIF-1-alpha transcription factor network—AKT1—epilepsy syndrome	6.67e-06	6.14e-05	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—TNF—epilepsy syndrome	6.67e-06	6.14e-05	CbGpPWpGaD
Captopril—ABCB1—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	6.6e-06	6.07e-05	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	6.56e-06	6.04e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—SLCO1A2—epilepsy syndrome	6.52e-06	6e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—CACNA2D2—epilepsy syndrome	6.52e-06	6e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—SLC6A8—epilepsy syndrome	6.52e-06	6e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—PFKL—epilepsy syndrome	6.52e-06	6e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—KCNB1—epilepsy syndrome	6.52e-06	6e-05	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—PRKCB—epilepsy syndrome	6.51e-06	5.99e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—TSC1—epilepsy syndrome	6.49e-06	5.98e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—PTK2B—epilepsy syndrome	6.49e-06	5.98e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—S100B—epilepsy syndrome	6.48e-06	5.97e-05	CbGpPWpGaD
Captopril—ABCB1—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	6.43e-06	5.92e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—SOCS3—epilepsy syndrome	6.42e-06	5.91e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CDC42—epilepsy syndrome	6.4e-06	5.9e-05	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—AGT—epilepsy syndrome	6.4e-06	5.89e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—AKT3—epilepsy syndrome	6.34e-06	5.84e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—NEU1—epilepsy syndrome	6.33e-06	5.82e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—UPB1—epilepsy syndrome	6.33e-06	5.82e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—ATIC—epilepsy syndrome	6.33e-06	5.82e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—NTRK2—epilepsy syndrome	6.32e-06	5.82e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CCR2—epilepsy syndrome	6.32e-06	5.82e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—SST—epilepsy syndrome	6.32e-06	5.82e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—ASAH1—epilepsy syndrome	6.31e-06	5.81e-05	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—epilepsy syndrome	6.29e-06	5.79e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—PLAUR—epilepsy syndrome	6.27e-06	5.77e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—DUSP6—epilepsy syndrome	6.26e-06	5.76e-05	CbGpPWpGaD
Captopril—ALB—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	6.24e-06	5.74e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—AVP—epilepsy syndrome	6.2e-06	5.71e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—ADRA2A—epilepsy syndrome	6.18e-06	5.69e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—PLAT—epilepsy syndrome	6.16e-06	5.67e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—STXBP1—epilepsy syndrome	6.14e-06	5.65e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—HSD17B4—epilepsy syndrome	6.09e-06	5.61e-05	CbGpPWpGaD
Captopril—F2—Hemostasis—SRC—epilepsy syndrome	6.05e-06	5.57e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—NT5E—epilepsy syndrome	5.98e-06	5.51e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—ALAD—epilepsy syndrome	5.98e-06	5.51e-05	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—epilepsy syndrome	5.97e-06	5.5e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—ATIC—epilepsy syndrome	5.96e-06	5.49e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—UPB1—epilepsy syndrome	5.96e-06	5.49e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—NEU1—epilepsy syndrome	5.96e-06	5.49e-05	CbGpPWpGaD
Captopril—ALB—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	5.95e-06	5.48e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CXCL12—epilepsy syndrome	5.94e-06	5.47e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—BDKRB2—epilepsy syndrome	5.94e-06	5.47e-05	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—POMC—epilepsy syndrome	5.93e-06	5.46e-05	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—PRKCB—epilepsy syndrome	5.91e-06	5.44e-05	CbGpPWpGaD
Captopril—F2—Hemostasis—VEGFA—epilepsy syndrome	5.9e-06	5.43e-05	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—IL6ST—epilepsy syndrome	5.89e-06	5.42e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—PPP1R3C—epilepsy syndrome	5.88e-06	5.41e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—GBE1—epilepsy syndrome	5.88e-06	5.41e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—HES1—epilepsy syndrome	5.86e-06	5.4e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—JUNB—epilepsy syndrome	5.83e-06	5.37e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CNR1—epilepsy syndrome	5.83e-06	5.37e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—PLCB1—epilepsy syndrome	5.81e-06	5.35e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—CDC42—epilepsy syndrome	5.79e-06	5.33e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—HSD17B4—epilepsy syndrome	5.74e-06	5.28e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—CACNA1A—epilepsy syndrome	5.71e-06	5.25e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—ALDH7A1—epilepsy syndrome	5.71e-06	5.25e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—FYN—epilepsy syndrome	5.7e-06	5.25e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—HTR7—epilepsy syndrome	5.69e-06	5.24e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—H2AFX—epilepsy syndrome	5.68e-06	5.23e-05	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—epilepsy syndrome	5.67e-06	5.22e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—MEF2C—epilepsy syndrome	5.67e-06	5.22e-05	CbGpPWpGaD
Captopril—SLC22A6—Transmembrane transport of small molecules—ALB—epilepsy syndrome	5.65e-06	5.2e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—ST3GAL3—epilepsy syndrome	5.58e-06	5.14e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—GBE1—epilepsy syndrome	5.54e-06	5.1e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—PPP1R3C—epilepsy syndrome	5.54e-06	5.1e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—ASAH1—epilepsy syndrome	5.53e-06	5.09e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—HBEGF—epilepsy syndrome	5.52e-06	5.08e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—YWHAZ—epilepsy syndrome	5.48e-06	5.05e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—ADSL—epilepsy syndrome	5.47e-06	5.04e-05	CbGpPWpGaD
Captopril—ABCB1—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	5.46e-06	5.03e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—AKT3—epilepsy syndrome	5.42e-06	4.99e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—NGF—epilepsy syndrome	5.42e-06	4.99e-05	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—POMC—epilepsy syndrome	5.39e-06	4.96e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—STXBP1—epilepsy syndrome	5.38e-06	4.95e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—GLUL—epilepsy syndrome	5.37e-06	4.94e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—ADAM10—epilepsy syndrome	5.29e-06	4.87e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CCR5—epilepsy syndrome	5.27e-06	4.85e-05	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—CCL2—epilepsy syndrome	5.27e-06	4.85e-05	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—epilepsy syndrome	5.27e-06	4.85e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—CACNA1D—epilepsy syndrome	5.27e-06	4.85e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—NT5E—epilepsy syndrome	5.24e-06	4.82e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—ALAD—epilepsy syndrome	5.24e-06	4.82e-05	CbGpPWpGaD
Captopril—ABCB1—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	5.21e-06	4.8e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—ASAH1—epilepsy syndrome	5.21e-06	4.8e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—HTR2A—epilepsy syndrome	5.16e-06	4.75e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—FYN—epilepsy syndrome	5.15e-06	4.74e-05	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—epilepsy syndrome	5.12e-06	4.71e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—STXBP1—epilepsy syndrome	5.07e-06	4.67e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—S100B—epilepsy syndrome	5.01e-06	4.61e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—CACNA1A—epilepsy syndrome	5e-06	4.6e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—ALDH7A1—epilepsy syndrome	5e-06	4.6e-05	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—AKT1—epilepsy syndrome	4.97e-06	4.57e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—SOCS3—epilepsy syndrome	4.96e-06	4.56e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—YWHAZ—epilepsy syndrome	4.95e-06	4.56e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CDC42—epilepsy syndrome	4.95e-06	4.55e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—NT5E—epilepsy syndrome	4.94e-06	4.55e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—ALAD—epilepsy syndrome	4.94e-06	4.55e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—TXNRD1—epilepsy syndrome	4.93e-06	4.53e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—TSC2—epilepsy syndrome	4.9e-06	4.51e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—AGT—epilepsy syndrome	4.9e-06	4.51e-05	CbGpPWpGaD
Captopril—ALB—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	4.89e-06	4.51e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—ST3GAL3—epilepsy syndrome	4.89e-06	4.5e-05	CbGpPWpGaD
Captopril—ALB—Transmembrane transport of small molecules—AVP—epilepsy syndrome	4.85e-06	4.47e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—APOE—epilepsy syndrome	4.8e-06	4.42e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—ADSL—epilepsy syndrome	4.79e-06	4.41e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—AVP—epilepsy syndrome	4.79e-06	4.41e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—AQP1—epilepsy syndrome	4.78e-06	4.4e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—CACNA1A—epilepsy syndrome	4.71e-06	4.34e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—ALDH7A1—epilepsy syndrome	4.71e-06	4.34e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—GLUL—epilepsy syndrome	4.7e-06	4.33e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—KDR—epilepsy syndrome	4.7e-06	4.33e-05	CbGpPWpGaD
Captopril—ALB—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	4.7e-06	4.32e-05	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—SRC—epilepsy syndrome	4.66e-06	4.29e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—CACNA1D—epilepsy syndrome	4.61e-06	4.25e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—ST3GAL3—epilepsy syndrome	4.61e-06	4.24e-05	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	4.59e-06	4.23e-05	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—epilepsy syndrome	4.59e-06	4.22e-05	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—VEGFA—epilepsy syndrome	4.54e-06	4.18e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—HES1—epilepsy syndrome	4.53e-06	4.17e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—PRKCB—epilepsy syndrome	4.52e-06	4.16e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—ADSL—epilepsy syndrome	4.52e-06	4.16e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—IL6ST—epilepsy syndrome	4.51e-06	4.15e-05	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—epilepsy syndrome	4.47e-06	4.11e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—GLUL—epilepsy syndrome	4.43e-06	4.08e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—FYN—epilepsy syndrome	4.4e-06	4.05e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—PLAU—epilepsy syndrome	4.4e-06	4.05e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—H2AFX—epilepsy syndrome	4.39e-06	4.04e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—MEF2C—epilepsy syndrome	4.38e-06	4.03e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—CACNA1D—epilepsy syndrome	4.35e-06	4e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—CHRM3—epilepsy syndrome	4.32e-06	3.98e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—KCNJ11—epilepsy syndrome	4.32e-06	3.98e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—TXNRD1—epilepsy syndrome	4.32e-06	3.97e-05	CbGpPWpGaD
Captopril—ABCB1—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	4.29e-06	3.95e-05	CbGpPWpGaD
Captopril—ABCB1—Transmembrane transport of small molecules—AVP—epilepsy syndrome	4.25e-06	3.91e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—YWHAZ—epilepsy syndrome	4.23e-06	3.9e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—AQP1—epilepsy syndrome	4.19e-06	3.86e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—NGF—epilepsy syndrome	4.18e-06	3.85e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—POMC—epilepsy syndrome	4.12e-06	3.79e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—PRKCB—epilepsy syndrome	4.09e-06	3.76e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CCR5—epilepsy syndrome	4.07e-06	3.75e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—TXNRD1—epilepsy syndrome	4.07e-06	3.74e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—NOS2—epilepsy syndrome	4.04e-06	3.72e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CCL2—epilepsy syndrome	4.03e-06	3.71e-05	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	4.03e-06	3.71e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—HTR2A—epilepsy syndrome	3.98e-06	3.67e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—AQP1—epilepsy syndrome	3.95e-06	3.63e-05	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	3.95e-06	3.63e-05	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—epilepsy syndrome	3.83e-06	3.53e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—KCNJ11—epilepsy syndrome	3.79e-06	3.49e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—CHRM3—epilepsy syndrome	3.79e-06	3.49e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—TSC2—epilepsy syndrome	3.78e-06	3.48e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—AGT—epilepsy syndrome	3.78e-06	3.48e-05	CbGpPWpGaD
Captopril—F2—Hemostasis—AKT1—epilepsy syndrome	3.76e-06	3.46e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—APOE—epilepsy syndrome	3.7e-06	3.41e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—FGF2—epilepsy syndrome	3.64e-06	3.35e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—KDR—epilepsy syndrome	3.63e-06	3.34e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—CHRM3—epilepsy syndrome	3.57e-06	3.29e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—KCNJ11—epilepsy syndrome	3.57e-06	3.29e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—ABCG2—epilepsy syndrome	3.53e-06	3.25e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—PRKCB—epilepsy syndrome	3.49e-06	3.22e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—IL6ST—epilepsy syndrome	3.48e-06	3.2e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—CYP2C19—epilepsy syndrome	3.44e-06	3.16e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—CYP11A1—epilepsy syndrome	3.41e-06	3.14e-05	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	3.39e-06	3.12e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—RELA—epilepsy syndrome	3.38e-06	3.11e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—MTOR—epilepsy syndrome	3.32e-06	3.05e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—POMC—epilepsy syndrome	3.18e-06	2.93e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CCL2—epilepsy syndrome	3.11e-06	2.87e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—ABCG2—epilepsy syndrome	3.09e-06	2.84e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—CYP2D6—epilepsy syndrome	3.08e-06	2.84e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CASP3—epilepsy syndrome	3.05e-06	2.81e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—CYP2C19—epilepsy syndrome	3.01e-06	2.77e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—CYP11A1—epilepsy syndrome	2.99e-06	2.75e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—JUN—epilepsy syndrome	2.96e-06	2.73e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—ADRA2A—epilepsy syndrome	2.93e-06	2.7e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—BCHE—epilepsy syndrome	2.92e-06	2.69e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—ABCG2—epilepsy syndrome	2.91e-06	2.68e-05	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—AKT1—epilepsy syndrome	2.9e-06	2.67e-05	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	2.85e-06	2.62e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—CYP2C19—epilepsy syndrome	2.84e-06	2.61e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—CYP11A1—epilepsy syndrome	2.82e-06	2.6e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—FGF2—epilepsy syndrome	2.81e-06	2.59e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—SLC2A1—epilepsy syndrome	2.79e-06	2.57e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—PLCB1—epilepsy syndrome	2.76e-06	2.54e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—TH—epilepsy syndrome	2.75e-06	2.53e-05	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	2.7e-06	2.49e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—CYP2D6—epilepsy syndrome	2.7e-06	2.49e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—SRC—epilepsy syndrome	2.66e-06	2.45e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—RELA—epilepsy syndrome	2.61e-06	2.4e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—VEGFA—epilepsy syndrome	2.59e-06	2.38e-05	CbGpPWpGaD
Captopril—ABCB1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	2.57e-06	2.37e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—ADRA2A—epilepsy syndrome	2.57e-06	2.37e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—MTOR—epilepsy syndrome	2.56e-06	2.36e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—BCHE—epilepsy syndrome	2.56e-06	2.36e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—SLC2A1—epilepsy syndrome	2.44e-06	2.25e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—ADRA2A—epilepsy syndrome	2.42e-06	2.23e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—PLCB1—epilepsy syndrome	2.42e-06	2.22e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—BCHE—epilepsy syndrome	2.41e-06	2.22e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—TH—epilepsy syndrome	2.41e-06	2.22e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—SRC—epilepsy syndrome	2.4e-06	2.21e-05	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—AKT1—epilepsy syndrome	2.38e-06	2.19e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CASP3—epilepsy syndrome	2.36e-06	2.17e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—VEGFA—epilepsy syndrome	2.34e-06	2.15e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—SLC2A1—epilepsy syndrome	2.3e-06	2.12e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—HMOX1—epilepsy syndrome	2.29e-06	2.11e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—JUN—epilepsy syndrome	2.29e-06	2.11e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—PLCB1—epilepsy syndrome	2.28e-06	2.1e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—TH—epilepsy syndrome	2.27e-06	2.09e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—CAT—epilepsy syndrome	2.26e-06	2.08e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—MMP9—epilepsy syndrome	2.23e-06	2.05e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—ABCB1—epilepsy syndrome	2.2e-06	2.03e-05	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—AKT1—epilepsy syndrome	2.16e-06	1.99e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—SRC—epilepsy syndrome	2.05e-06	1.89e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—GPX1—epilepsy syndrome	2.05e-06	1.88e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—HMOX1—epilepsy syndrome	2.01e-06	1.85e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—VEGFA—epilepsy syndrome	2e-06	1.84e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—CAT—epilepsy syndrome	1.98e-06	1.82e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—HMOX1—epilepsy syndrome	1.89e-06	1.74e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—CAT—epilepsy syndrome	1.87e-06	1.72e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—ABCB1—epilepsy syndrome	1.82e-06	1.67e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—AGT—epilepsy syndrome	1.79e-06	1.65e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—GPX1—epilepsy syndrome	1.79e-06	1.65e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—APOE—epilepsy syndrome	1.76e-06	1.62e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—GPX1—epilepsy syndrome	1.69e-06	1.55e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—AKT1—epilepsy syndrome	1.65e-06	1.52e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—AGT—epilepsy syndrome	1.57e-06	1.45e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—APOE—epilepsy syndrome	1.54e-06	1.42e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—POMC—epilepsy syndrome	1.51e-06	1.39e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—AKT1—epilepsy syndrome	1.49e-06	1.37e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—AGT—epilepsy syndrome	1.48e-06	1.36e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—APOE—epilepsy syndrome	1.45e-06	1.34e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—POMC—epilepsy syndrome	1.32e-06	1.22e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—AKT1—epilepsy syndrome	1.28e-06	1.17e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—POMC—epilepsy syndrome	1.25e-06	1.15e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—ALB—epilepsy syndrome	1.21e-06	1.11e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—PTGS2—epilepsy syndrome	1.2e-06	1.11e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—ALB—epilepsy syndrome	1.14e-06	1.05e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—PTGS2—epilepsy syndrome	1.06e-06	9.71e-06	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—PTGS2—epilepsy syndrome	9.94e-07	9.15e-06	CbGpPWpGaD
Captopril—ALB—Metabolism—AKT1—epilepsy syndrome	6.05e-07	5.57e-06	CbGpPWpGaD
Captopril—ABCB1—Metabolism—AKT1—epilepsy syndrome	5.3e-07	4.88e-06	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—AKT1—epilepsy syndrome	5e-07	4.6e-06	CbGpPWpGaD
